S243249 Monotherapy in Patients With Relapsed or Refractory Acute Leukemia With a KMT2A or NUP98 Translocation or Relapsed or Refractory AML With NPM1c Mutation

Clinical trial NCT07722312 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07722312
Sponsor: Servier
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed or Refractory Acute Leukemia Relapsed or Refractory Acute Myeloid Leukemia

Start date: 2026-09-20
Primary completion: 2029-08-11
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.